EFFECTS OF IMMUNOSTIMULANTS ON THE INVITRO GENERATION OF CYTO-TOXIC LYMPHOCYTES AGAINST CERVICAL-CANCER CELL-LINES

被引:0
作者
MASHIBA, H [1 ]
MATSUNAGA, K [1 ]
JIMI, S [1 ]
机构
[1] NATL KYUSHU CANC CTR, DEPT GYNECOL, FUKUOKA 815, JAPAN
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:235 / 241
页数:7
相关论文
共 50 条
[21]   SENSITIZATION OF LYMPHOCYTES AGAINST POOLED ALLOGENEIC CELLS .2. CHARACTERIZATION OF EFFECTOR-CELLS CYTO-TOXIC FOR AUTOLOGOUS LYMPHOBLASTOID CELL-LINES [J].
ZARLING, JM ;
BACH, FH ;
KUNG, PC .
JOURNAL OF IMMUNOLOGY, 1981, 126 (01) :375-378
[22]   EFFECT OF AMINOBENZAMIDE ON THE CYTO-TOXIC EFFICACY OF CISPLATIN IN 2 HUMAN OVARIAN-CANCER CELL-LINES [J].
UMBACH, GE ;
POETHEN, J ;
VONMATTHIESSEN, H ;
KOLDOVSKY, U .
IRCS MEDICAL SCIENCE-BIOCHEMISTRY, 1985, 13 (07) :578-578
[23]   CELL-MEDIATED CYTOTOXICITY INVITRO OF HUMAN LYMPHOCYTES AGAINST A CERVICAL-CANCER CELL LINE [J].
MASHIBA, H ;
MATSUNAGA, K ;
UENO, M ;
JIMI, S .
GANN, 1977, 68 (01) :53-58
[24]   ALPHA-INTERFERON IN COMBINATION WITH CYTO-TOXIC DRUGS AGAINST HUMAN-LUNG CARCINOMA CELL-LINES [J].
FERGUSSON, RJ ;
LANGDON, SP ;
HAWKES, MM ;
SMYTH, JF .
BRITISH JOURNAL OF CANCER, 1988, 58 (02) :247-247
[27]   CROSS-RESISTANCE TO CYTO-TOXIC DRUGS IN HUMAN GLIOMA CELL-LINES IN CULTURE [J].
MERRY, S ;
KAYE, SB ;
FRESHNEY, RI .
BRITISH JOURNAL OF CANCER, 1984, 50 (06) :831-835
[28]   CYTO-TOXIC EFFECTS OF TRIMETHYLTIN CHLORIDE ON HUMAN PERIPHERAL-BLOOD LYMPHOCYTES INVITRO [J].
GHOSH, BB ;
TALUKDER, G ;
SHARMA, A .
HUMAN TOXICOLOGY, 1989, 8 (05) :349-353
[29]   NONSPECIFIC SUPPRESSION OF INVITRO GENERATION OF CYTO-TOXIC LYMPHOCYTES BY ALLOGENEIC AND XENOGENEIC EMBRYONIC-TISSUES [J].
CROY, BA ;
ROSSANT, J ;
CLARK, DA ;
WEGMANN, TG .
TRANSPLANTATION, 1983, 35 (06) :627-629
[30]   MECHANISMS OF INVIVO GENERATION OF CYTO-TOXIC ACTIVITY AGAINST ALLOGRAFT .1. LOCAL DIFFERENTIATION OF MATURE CYTO-TOXIC LYMPHOCYTES-T IN REJECTION OF ALLOGENEIC LYMPHOCYTES [J].
SAKEMI, T ;
KUROIWA, A ;
TANIGUCHI, K ;
NOMOTO, K .
CELLULAR IMMUNOLOGY, 1980, 54 (02) :321-329